Soluble adenylyl cyclase contributes to imiquimod‐mediated inflammation and is a potential therapeutic target in psoriasis is a research paper published in Experimental Dermatology (2023). On theSindex it has a DataRank of 0.158. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0.0542
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: 1 R01 AR077664‐01A1
Pfizer
Grant: AspireAward
National Cancer Institute
Grant: 1R21CA224391‐01A1
NIAMS NIH HHS
Grant: R01 AR077664
NCI NIH HHS
Grant: R21 CA224391
FWCI
0.09
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals